Refractory Anemia With Ring Sideroblasts: Clinical Trials

2 trials for Refractory Anemia With Ring Sideroblasts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Refractory Anemia With Ring Sideroblasts: new trials by email Literature Review of Refractory Anemia With Ring Sideroblasts trials Research Report on Refractory Anemia With Ring Sideroblasts

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Fludarabine, Total-Body Irradiation, T Cell-Depleted Donor Lymphocyte Infusion - Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University352015-11-132025-04-24
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
Cyclosporine, Fludarabine Phosphate, Laboratory Biomarker Analysis - Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia
Phase 2CompletedFred Hutchinson Cancer Center772006-01-012020-01-31

Narrower conditions

Anemia, Refractory (2)  ·  Anemia, Refractory, with Excess of Blasts (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Myeloproliferative Disorders (2)  ·  Anemia, Aplastic (1)  ·  Hemoglobinuria, Paroxysmal (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Polycythemia Vera (1)  ·  Primary Myelofibrosis (1)  ·  Thrombocythemia, Essential (1)

Broader conditions

Anemia (2)  ·  Bone Marrow Diseases (2)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Myelodysplastic-Myeloproliferative Diseases (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Anemia, Hemolytic (1)  ·  Blood Coagulation Disorders (1)

Interventions

Mycophenolic Acid (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Whole-Body Irradiation (2)  ·  fludarabine phosphate (2)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Tacrolimus (1)  ·  fludarabine (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (2)

Top investigators

Brenda Sandmaier (1)  ·  Usama Gergis, MD (1)

Results publications

PMID 30630975, PMID 32499241

NIH funding

P01CA018029 (1), P30CA015704 (1)